25 XP   0   0   10

Elanco Animal Health
Buy, Hold or Sell?

Let's analyse Elanco together

PenkeI guess you are interested in Elanco Animal Health. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Elanco Animal Health. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Elanco Animal Health

I send you an email if I find something interesting about Elanco Animal Health.

Quick analysis of Elanco (30 sec.)










What can you expect buying and holding a share of Elanco? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$12.62
Expected worth in 1 year
$10.46
How sure are you?
46.4%

+ What do you gain per year?

Total Gains per Share
$-2.16
Return On Investment
-16.2%

For what price can you sell your share?

Current Price per Share
$13.31
Expected price per share
$12.07 - $14.45
How sure are you?
50%

1. Valuation of Elanco (5 min.)




Live pricePrice per Share (EOD)

$13.31

Intrinsic Value Per Share

$37.03 - $44.41

Total Value Per Share

$49.65 - $57.04

2. Growth of Elanco (5 min.)




Is Elanco growing?

Current yearPrevious yearGrowGrow %
How rich?$6.2b$7.1b-$382.2m-5.6%

How much money is Elanco making?

Current yearPrevious yearGrowGrow %
Making money-$307.7m-$18.5m-$289.2m-94.0%
Net Profit Margin-29.3%-2.0%--

How much money comes from the company's main activities?

3. Financial Health of Elanco (5 min.)




What can you expect buying and holding a share of Elanco? (5 min.)

Welcome investor! Elanco's management wants to use your money to grow the business. In return you get a share of Elanco.

What can you expect buying and holding a share of Elanco?

First you should know what it really means to hold a share of Elanco. And how you can make/lose money.

Speculation

The Price per Share of Elanco is $13.31. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Elanco.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Elanco, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $12.62. Based on the TTM, the Book Value Change Per Share is $-0.54 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Elanco.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.29-2.1%-0.62-4.7%-0.04-0.3%-0.23-1.7%-0.18-1.4%
Usd Book Value Change Per Share0.181.4%-0.54-4.1%-0.13-0.9%0.100.8%0.453.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.181.4%-0.54-4.1%-0.13-0.9%0.100.8%0.453.4%
Usd Price Per Share14.90-11.40-17.59-23.24-18.97-
Price to Earnings Ratio-13.02--3.96--25.39--11.35-2.90-
Price-to-Total Gains Ratio82.53-4.96-37.22--661.53--590.02-
Price to Book Ratio1.18-0.84-1.19-1.70-1.44-
Price-to-Total Gains Ratio82.53-4.96-37.22--661.53--590.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share13.31
Number of shares75
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.540.10
Usd Total Gains Per Share-0.540.10
Gains per Quarter (75 shares)-40.557.80
Gains per Year (75 shares)-162.1831.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-162-17203121
20-324-33406252
30-487-49609483
40-649-6580125114
50-811-8200156145
60-973-9820187176
70-1135-11440218207
80-1297-13060250238
90-1460-14680281269
100-1622-16300312300

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%9.019.00.032.1%9.019.00.032.1%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%13.012.03.046.4%13.012.03.046.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%10.010.00.050.0%13.012.03.046.4%13.012.03.046.4%

Fundamentals of Elanco

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Fundamental data was last updated by Penke on 2024-04-13 13:00:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Elanco Animal Health.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Elanco earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -13.6% means that $-0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Elanco Animal Health:

  • The MRQ is -13.6%. The company is making a huge loss. -2
  • The TTM is -29.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-13.6%TTM-29.3%+15.7%
TTM-29.3%YOY-2.0%-27.3%
TTM-29.3%5Y-10.8%-18.5%
5Y-10.8%10Y-8.5%-2.2%
1.1.2. Return on Assets

Shows how efficient Elanco is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.0% Return on Assets means that Elanco generated $-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Elanco Animal Health:

  • The MRQ is -1.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.0%TTM-2.1%+1.2%
TTM-2.1%YOY-0.1%-2.0%
TTM-2.1%5Y-0.7%-1.4%
5Y-0.7%10Y-0.6%-0.1%
1.1.3. Return on Equity

Shows how efficient Elanco is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.3% Return on Equity means Elanco generated $-0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Elanco Animal Health:

  • The MRQ is -2.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM-5.0%+2.8%
TTM-5.0%YOY-0.3%-4.7%
TTM-5.0%5Y-1.6%-3.4%
5Y-1.6%10Y-1.3%-0.4%

1.2. Operating Efficiency of Elanco Animal Health.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Elanco is operating .

  • Measures how much profit Elanco makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -2.3% means the company generated $-0.02  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Elanco Animal Health:

  • The MRQ is -2.3%. The company is operating very inefficient. -2
  • The TTM is 5.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ-2.3%TTM5.1%-7.4%
TTM5.1%YOY7.5%-2.4%
TTM5.1%5Y6.9%-1.8%
5Y6.9%10Y8.5%-1.6%
1.2.2. Operating Ratio

Measures how efficient Elanco is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are $0.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Elanco Animal Health:

  • The MRQ is 0.990. The company is less efficient in keeping operating costs low.
  • The TTM is 0.931. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.990TTM0.931+0.059
TTM0.931YOY0.916+0.016
TTM0.9315Y0.935-0.003
5Y0.93510Y0.951-0.016

1.3. Liquidity of Elanco Animal Health.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Elanco is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.75 means the company has $2.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Elanco Animal Health:

  • The MRQ is 2.745. The company is able to pay all its short-term debts. +1
  • The TTM is 2.664. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.745TTM2.664+0.081
TTM2.664YOY2.199+0.465
TTM2.6645Y2.553+0.111
5Y2.55310Y2.498+0.055
1.3.2. Quick Ratio

Measures if Elanco is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.10 means the company can pay off $1.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Elanco Animal Health:

  • The MRQ is 1.098. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.141. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.098TTM1.141-0.044
TTM1.141YOY1.033+0.108
TTM1.1415Y1.270-0.129
5Y1.27010Y1.281-0.011

1.4. Solvency of Elanco Animal Health.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Elanco assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Elanco to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.57 means that Elanco assets are financed with 56.7% credit (debt) and the remaining percentage (100% - 56.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Elanco Animal Health:

  • The MRQ is 0.567. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.549. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.549+0.018
TTM0.549YOY0.538+0.011
TTM0.5495Y0.487+0.062
5Y0.48710Y0.405+0.081
1.4.2. Debt to Equity Ratio

Measures if Elanco is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 130.8% means that company has $1.31 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Elanco Animal Health:

  • The MRQ is 1.308. The company is able to pay all its debts with equity. +1
  • The TTM is 1.221. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.308TTM1.221+0.087
TTM1.221YOY1.165+0.055
TTM1.2215Y0.991+0.230
5Y0.99110Y0.792+0.198

2. Market Valuation of Elanco Animal Health

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Elanco generates.

  • Above 15 is considered overpriced but always compare Elanco to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -13.02 means the investor is paying $-13.02 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Elanco Animal Health:

  • The EOD is -11.634. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.023. Based on the earnings, the company is expensive. -2
  • The TTM is -3.955. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.634MRQ-13.023+1.390
MRQ-13.023TTM-3.955-9.068
TTM-3.955YOY-25.393+21.438
TTM-3.9555Y-11.352+7.397
5Y-11.35210Y2.904-14.257
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Elanco Animal Health:

  • The EOD is 14.141. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 15.830. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 20.787. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD14.141MRQ15.830-1.689
MRQ15.830TTM20.787-4.957
TTM20.787YOY-9.998+30.785
TTM20.7875Y39.764-18.976
5Y39.76410Y31.204+8.560
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Elanco is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Elanco Animal Health:

  • The EOD is 1.054. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.180. Based on the equity, the company is underpriced. +1
  • The TTM is 0.843. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.054MRQ1.180-0.126
MRQ1.180TTM0.843+0.337
TTM0.843YOY1.195-0.352
TTM0.8435Y1.695-0.852
5Y1.69510Y1.437+0.258
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Elanco Animal Health.

3.1. Institutions holding Elanco Animal Health

Institutions are holding 99.15% of the shares of Elanco Animal Health.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Dodge & Cox17.03570.794283980900-222400-0.2641
2023-12-31PRIMECAP Management Company10.26440.59695060032414316652.9117
2023-12-31Vanguard Group Inc10.03480.0161494686374671960.9534
2023-12-31BlackRock Inc5.6360.0106277835556644832.4502
2023-12-31Black Creek Investment Management Inc4.399810.59421689508616605139.7209
2023-12-31T. Rowe Price Associates, Inc.4.31810.04262128673713657316.8557
2023-12-31Dimensional Fund Advisors, Inc.3.06210.065715095179381651433.8383
2023-12-31Shapiro Capital Management Co Inc2.95335.995914559024-1236690-7.8293
2023-09-30Citadel Advisors Llc2.80250.0333138156035591934.2183
2023-12-31Ancora Advisors LLC2.12953.6737104978687189251217.2887
2023-12-31State Street Corporation2.12550.0076104779248353618.6633
2023-12-31Geode Capital Management, LLC1.49030.011573465421973142.7599
2023-09-30Holocene Advisors, LP1.36250.33056716650174665435.144
2023-12-31Prudential Financial Inc1.30790.145164476903631002128.9103
2023-12-31JPMorgan Chase & Co1.29440.00916380906112588821.425
2023-12-31Nuveen Asset Management, LLC1.23540.02926090014233840562.3307
2023-12-31Morgan Stanley - Brokerage Accounts1.22480.00796037992188918745.5357
2023-12-31Wellington Management Company LLP1.18650.01635849081-381837-6.1281
2023-12-31T. Rowe Price Investment Management,Inc.1.18310.056558324883522982152.5427
2023-12-31Magnetar Financial LLC1.17392.18915786812-2108719-26.7078
Total 76.220524.6258375743434+32997231+8.8%

3.2. Funds holding Elanco Animal Health

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Dodge & Cox Stock I11.23730.81775539650000
2023-12-31Vanguard PRIMECAP Inv3.69520.3844182164396878003.9239
2024-02-29Vanguard Total Stock Mkt Idx Inv3.13530.015815456212-83199-0.5354
2024-02-29Vanguard Small Cap Index2.57670.1436127023331178050.9361
2023-12-31Vanguard Capital Opportunity Inv2.01980.706699567761860301.9039
2024-03-31CI Global Leaders Fund D1.81984.35268970879250000.2795
2024-02-29Vanguard Small Cap Value Index Inv1.75760.25898664541425550.4936
2023-12-31Vanguard PRIMECAP Core Inv1.54370.93776101882195002.97
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.47780.1134728535653430.0734
2023-12-31T. Rowe Price US Mid-Cap Value Equity1.35240.7216666681090107815.6282
2023-12-31T. Rowe Price Mid-Cap Value1.35240.723666681090107815.6282
2023-12-31Dodge & Cox Balanced I1.16830.6101575960000
2023-12-31Dodge & Cox Balanced Composite1.16830.6078575960000
2024-02-29DFA US Small Cap Value I1.06290.541352396111273302.4907
2023-12-31Dodge & Cox Global Stock I0.75560.5096372500000
2023-12-31PRIMECAP Odyssey Growth0.75240.80693709271373301.0166
2023-12-31T. Rowe Price U.S. Mid-Cap Val Eq Tr-Z0.68670.7138338505056801720.1637
2023-12-31PRIMECAP Odyssey Stock0.68350.8673336934100
2024-02-29Fidelity Extended Market Index0.61080.11553011082275350.9229
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.6050.11352982497664002.277
Total 39.461514.0604194533896+3829602+2.0%

3.3. Insider Transactions

Insiders are holding 0.646% of the shares of Elanco Animal Health.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-06R David HooverBUY2000016.14

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Elanco Animal Health compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.181-0.541+399%-0.126+170%0.104+74%0.451-60%
Book Value Per Share--12.62313.823-9%14.598-14%14.086-10%14.057-10%
Current Ratio--2.7452.664+3%2.199+25%2.553+8%2.498+10%
Debt To Asset Ratio--0.5670.549+3%0.538+5%0.487+16%0.405+40%
Debt To Equity Ratio--1.3081.221+7%1.165+12%0.991+32%0.792+65%
Dividend Per Share----0%-0%-0%-0%
Eps---0.286-0.624+118%-0.040-86%-0.231-19%-0.184-36%
Free Cash Flow Per Share--0.2350.059+297%0.136+73%0.035+571%0.056+317%
Free Cash Flow To Equity Per Share---0.0470.017-371%-0.143+205%0.464-110%0.381-112%
Gross Profit Margin--1.0001.0000%1.931-48%1.558-36%1.398-28%
Intrinsic Value_10Y_max--44.414--------
Intrinsic Value_10Y_min--37.026--------
Intrinsic Value_1Y_max--1.034--------
Intrinsic Value_1Y_min--1.013--------
Intrinsic Value_3Y_max--5.710--------
Intrinsic Value_3Y_min--5.399--------
Intrinsic Value_5Y_max--13.526--------
Intrinsic Value_5Y_min--12.330--------
Market Cap6561430487.040-12%7345252761.6005619857817.600+31%8670109593.600-15%11454404063.232-36%9351112414.354-21%
Net Profit Margin---0.136-0.293+115%-0.020-85%-0.108-21%-0.085-37%
Operating Margin---0.0230.051-145%0.075-131%0.069-134%0.085-127%
Operating Ratio--0.9900.931+6%0.916+8%0.935+6%0.951+4%
Pb Ratio1.054-12%1.1800.843+40%1.195-1%1.695-30%1.437-18%
Pe Ratio-11.634+11%-13.023-3.955-70%-25.393+95%-11.352-13%2.904-548%
Price Per Share13.310-12%14.90011.400+31%17.588-15%23.236-36%18.969-21%
Price To Free Cash Flow Ratio14.141-12%15.83020.787-24%-9.998+163%39.764-60%31.204-49%
Price To Total Gains Ratio73.724-12%82.5314.957+1565%37.222+122%-661.535+902%-590.017+815%
Quick Ratio--1.0981.141-4%1.033+6%1.270-14%1.281-14%
Return On Assets---0.010-0.021+119%-0.001-87%-0.007-25%-0.006-37%
Return On Equity---0.023-0.050+121%-0.003-88%-0.016-27%-0.013-45%
Total Gains Per Share--0.181-0.541+399%-0.126+170%0.104+74%0.451-60%
Usd Book Value--6223000000.0006814250000.000-9%7196500000.000-14%6943990000.000-10%6929464285.714-10%
Usd Book Value Change Per Share--0.181-0.541+399%-0.126+170%0.104+74%0.451-60%
Usd Book Value Per Share--12.62313.823-9%14.598-14%14.086-10%14.057-10%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.286-0.624+118%-0.040-86%-0.231-19%-0.184-36%
Usd Free Cash Flow--116000000.00029250000.000+297%67000000.000+73%17290000.000+571%27825000.000+317%
Usd Free Cash Flow Per Share--0.2350.059+297%0.136+73%0.035+571%0.056+317%
Usd Free Cash Flow To Equity Per Share---0.0470.017-371%-0.143+205%0.464-110%0.381-112%
Usd Market Cap6561430487.040-12%7345252761.6005619857817.600+31%8670109593.600-15%11454404063.232-36%9351112414.354-21%
Usd Price Per Share13.310-12%14.90011.400+31%17.588-15%23.236-36%18.969-21%
Usd Profit---141000000.000-307750000.000+118%-18500000.000-87%-113460000.000-20%-88466071.429-37%
Usd Revenue--1035000000.0001104250000.000-6%1104500000.000-6%997215000.000+4%1003385714.286+3%
Usd Total Gains Per Share--0.181-0.541+399%-0.126+170%0.104+74%0.451-60%
 EOD+3 -5MRQTTM+20 -13YOY+14 -205Y+14 -2010Y+10 -24

4.2. Fundamental Score

Let's check the fundamental score of Elanco Animal Health based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.634
Price to Book Ratio (EOD)Between0-11.054
Net Profit Margin (MRQ)Greater than0-0.136
Operating Margin (MRQ)Greater than0-0.023
Quick Ratio (MRQ)Greater than11.098
Current Ratio (MRQ)Greater than12.745
Debt to Asset Ratio (MRQ)Less than10.567
Debt to Equity Ratio (MRQ)Less than11.308
Return on Equity (MRQ)Greater than0.15-0.023
Return on Assets (MRQ)Greater than0.05-0.010
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Elanco Animal Health based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.540
Ma 20Greater thanMa 5014.611
Ma 50Greater thanMa 10015.474
Ma 100Greater thanMa 20014.989
OpenGreater thanClose13.450
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
EBIT  6,000206,000212,000-182,00030,0003,00033,000-57,000-24,000
Operating Income  6,000206,000212,000-159,00053,000-11,00042,000-66,000-24,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets14,362,000
Total Liabilities8,139,000
Total Stockholder Equity6,223,000
 As reported
Total Liabilities 8,139,000
Total Stockholder Equity+ 6,223,000
Total Assets = 14,362,000

Assets

Total Assets14,362,000
Total Current Assets3,407,000
Long-term Assets10,955,000
Total Current Assets
Cash And Cash Equivalents 352,000
Net Receivables 1,010,000
Inventory 1,735,000
Other Current Assets 310,000
Total Current Assets  (as reported)3,407,000
Total Current Assets  (calculated)3,407,000
+/-0
Long-term Assets
Property Plant Equipment 1,026,000
Goodwill 5,094,000
Intangible Assets 4,494,000
Long-term Assets Other 341,000
Long-term Assets  (as reported)10,955,000
Long-term Assets  (calculated)10,955,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,241,000
Long-term Liabilities6,898,000
Total Stockholder Equity6,223,000
Total Current Liabilities
Short-term Debt 38,000
Short Long Term Debt 38,000
Accounts payable 270,000
Other Current Liabilities 409,000
Total Current Liabilities  (as reported)1,241,000
Total Current Liabilities  (calculated)755,000
+/- 486,000
Long-term Liabilities
Long term Debt 5,736,000
Long-term Liabilities Other 411,000
Long-term Liabilities  (as reported)6,898,000
Long-term Liabilities  (calculated)6,147,000
+/- 751,000
Total Stockholder Equity
Retained Earnings -2,288,000
Accumulated Other Comprehensive Income -266,000
Other Stockholders Equity 8,777,000
Total Stockholder Equity (as reported)6,223,000
Total Stockholder Equity (calculated)6,223,000
+/-0
Other
Cash and Short Term Investments 352,000
Common Stock Shares Outstanding 492,800
Current Deferred Revenue524,000
Liabilities and Stockholders Equity 14,362,000
Net Debt 5,422,000
Net Invested Capital 11,997,000
Net Working Capital 2,166,000
Property Plant and Equipment Gross 1,841,000
Short Long Term Debt Total 5,774,000



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-03-312016-12-31
> Total Assets 
8,099,700
0
8,940,300
8,940,300
8,577,400
8,577,400
9,211,500
8,956,700
8,747,400
8,856,900
8,823,700
8,985,800
9,727,200
9,876,000
17,237,000
17,692,700
16,988,000
16,833,000
16,565,000
16,483,000
16,251,000
15,601,000
14,948,000
15,491,000
15,769,000
15,796,000
14,344,000
14,362,000
14,362,00014,344,00015,796,00015,769,00015,491,00014,948,00015,601,00016,251,00016,483,00016,565,00016,833,00016,988,00017,692,70017,237,0009,876,0009,727,2008,985,8008,823,7008,856,9008,747,4008,956,7009,211,5008,577,4008,577,4008,940,3008,940,30008,099,700
   > Total Current Assets 
1,947,400
258,800
2,123,700
2,123,700
323,400
2,056,900
2,703,700
2,504,900
2,278,300
2,383,500
2,310,400
2,373,100
3,120,600
3,191,300
3,281,400
3,416,500
3,344,000
3,431,000
3,160,000
3,276,000
3,194,000
3,307,000
3,154,000
3,279,000
3,548,000
3,652,000
3,565,000
3,407,000
3,407,0003,565,0003,652,0003,548,0003,279,0003,154,0003,307,0003,194,0003,276,0003,160,0003,431,0003,344,0003,416,5003,281,4003,191,3003,120,6002,373,1002,310,4002,383,5002,278,3002,504,9002,703,7002,056,900323,4002,123,7002,123,700258,8001,947,400
       Cash And Cash Equivalents 
258,800
-258,800
323,400
323,400
-323,400
321,000
300,000
474,800
272,100
385,100
309,200
334,000
1,206,400
1,391,100
659,900
494,700
515,000
580,000
453,000
638,000
342,000
507,000
460,000
345,000
318,000
367,000
369,000
352,000
352,000369,000367,000318,000345,000460,000507,000342,000638,000453,000580,000515,000494,700659,9001,391,1001,206,400334,000309,200385,100272,100474,800300,000321,000-323,400323,400323,400-258,800258,800
       Short-term Investments 
0
517,600
0
0
646,800
0
634,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
18,000
3,000
14,000
8,000
40,000
0
0
0040,0008,00014,0003,00018,00000000000000000634,9000646,80000517,6000
       Net Receivables 
630,700
0
601,900
601,900
623,700
623,700
636,900
709,400
827,400
831,500
823,400
889,900
752,400
616,800
833,100
1,076,700
1,132,000
1,174,000
1,082,000
1,028,000
1,192,000
1,128,000
1,028,000
1,002,000
1,264,000
1,225,000
1,135,000
1,010,000
1,010,0001,135,0001,225,0001,264,0001,002,0001,028,0001,128,0001,192,0001,028,0001,082,0001,174,0001,132,0001,076,700833,100616,800752,400889,900823,400831,500827,400709,400636,900623,700623,700601,900601,9000630,700
       Inventory 
875,600
0
1,062,300
1,062,300
1,005,600
1,005,600
1,008,700
1,004,100
1,035,500
1,053,100
1,068,700
1,050,700
1,019,000
1,065,300
1,597,100
1,578,100
1,424,000
1,450,000
1,383,000
1,373,000
1,345,000
1,334,000
1,340,000
1,538,000
1,596,000
1,690,000
1,690,000
1,735,000
1,735,0001,690,0001,690,0001,596,0001,538,0001,340,0001,334,0001,345,0001,373,0001,383,0001,450,0001,424,0001,578,1001,597,1001,065,3001,019,0001,050,7001,068,7001,053,1001,035,5001,004,1001,008,7001,005,6001,005,6001,062,3001,062,3000875,600
       Other Current Assets 
182,300
0
0
136,100
0
106,600
123,200
113,900
114,800
102,300
98,000
87,400
132,100
107,400
180,600
256,300
273,000
227,000
242,000
237,000
315,000
338,000
326,000
394,000
370,000
370,000
371,000
310,000
310,000371,000370,000370,000394,000326,000338,000315,000237,000242,000227,000273,000256,300180,600107,400132,10087,40098,000102,300114,800113,900123,200106,6000136,10000182,300
   > Long-term Assets 
0
0
0
6,816,600
0
6,520,500
6,507,800
6,451,800
6,469,100
6,473,400
6,513,300
6,612,700
6,606,600
6,684,700
13,955,600
14,276,200
13,644,000
13,402,000
13,405,000
13,207,000
13,057,000
12,294,000
11,794,000
12,212,000
12,221,000
12,144,000
10,779,000
10,955,000
10,955,00010,779,00012,144,00012,221,00012,212,00011,794,00012,294,00013,057,00013,207,00013,405,00013,402,00013,644,00014,276,20013,955,6006,684,7006,606,6006,612,7006,513,3006,473,4006,469,1006,451,8006,507,8006,520,50006,816,600000
       Property Plant Equipment 
741,800
0
920,300
920,300
877,700
877,700
909,300
922,400
930,200
931,100
911,700
955,300
930,100
924,100
1,242,500
1,316,300
1,271,000
1,033,000
1,041,000
1,061,000
987,000
961,000
936,000
999,000
1,000,000
1,007,000
992,000
1,026,000
1,026,000992,0001,007,0001,000,000999,000936,000961,000987,0001,061,0001,041,0001,033,0001,271,0001,316,3001,242,500924,100930,100955,300911,700931,100930,200922,400909,300877,700877,700920,300920,3000741,800
       Goodwill 
2,576,500
0
2,969,200
2,969,200
2,932,300
2,932,300
2,968,800
2,958,000
2,933,100
2,959,600
2,946,400
2,989,600
3,004,000
3,044,000
6,434,700
6,224,800
6,016,000
6,239,000
6,191,000
6,172,000
6,116,000
5,898,000
5,716,000
5,993,000
6,061,000
6,040,000
4,902,000
5,094,000
5,094,0004,902,0006,040,0006,061,0005,993,0005,716,0005,898,0006,116,0006,172,0006,191,0006,239,0006,016,0006,224,8006,434,7003,044,0003,004,0002,989,6002,946,4002,959,6002,933,1002,958,0002,968,8002,932,3002,932,3002,969,2002,969,20002,576,500
       Long Term Investments 
9,000
0
12,300
12,300
12,800
12,800
14,900
15,300
15,700
16,300
40,700
21,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000021,10040,70016,30015,70015,30014,90012,80012,80012,30012,30009,000
       Intangible Assets 
5,197,500
0
2,672,800
2,672,800
2,534,900
2,534,900
2,514,800
2,453,000
2,386,500
2,352,800
2,435,000
2,482,800
2,455,500
2,432,700
5,785,600
6,387,300
6,032,000
5,755,000
5,816,000
5,587,000
5,395,000
5,059,000
4,766,000
4,842,000
4,791,000
4,678,000
4,475,000
4,494,000
4,494,0004,475,0004,678,0004,791,0004,842,0004,766,0005,059,0005,395,0005,587,0005,816,0005,755,0006,032,0006,387,3005,785,6002,432,7002,455,5002,482,8002,435,0002,352,8002,386,5002,453,0002,514,8002,534,9002,534,9002,672,8002,672,80005,197,500
       Long-term Assets Other 
0
0
0
242,000
0
162,800
100,000
103,100
219,300
229,900
220,200
185,000
217,000
283,900
492,800
347,800
325,000
375,000
357,000
387,000
559,000
376,000
376,000
378,000
369,000
419,000
410,000
341,000
341,000410,000419,000369,000378,000376,000376,000559,000387,000357,000375,000325,000347,800492,800283,900217,000185,000220,200229,900219,300103,100100,000162,8000242,000000
> Total Liabilities 
1,071,800
0
1,149,500
1,149,500
990,800
990,800
4,074,400
3,759,200
3,551,200
3,591,400
3,336,000
3,438,900
3,065,700
3,224,100
8,892,800
9,216,800
8,981,000
8,853,000
8,883,000
8,945,000
8,639,000
8,461,000
8,203,000
8,202,000
8,289,000
8,376,000
8,210,000
8,139,000
8,139,0008,210,0008,376,0008,289,0008,202,0008,203,0008,461,0008,639,0008,945,0008,883,0008,853,0008,981,0009,216,8008,892,8003,224,1003,065,7003,438,9003,336,0003,591,4003,551,2003,759,2004,074,400990,800990,8001,149,5001,149,50001,071,800
   > Total Current Liabilities 
618,900
0
632,600
632,600
558,400
558,400
1,245,400
970,700
708,200
777,500
741,500
818,500
707,500
835,400
1,871,200
2,076,300
2,034,000
1,990,000
1,362,000
1,643,000
1,307,000
1,338,000
1,613,000
1,702,000
1,578,000
1,284,000
1,265,000
1,241,000
1,241,0001,265,0001,284,0001,578,0001,702,0001,613,0001,338,0001,307,0001,643,0001,362,0001,990,0002,034,0002,076,3001,871,200835,400707,500818,500741,500777,500708,200970,7001,245,400558,400558,400632,600632,6000618,900
       Short-term Debt 
0
0
0
0
0
0
0
29,000
29,000
27,100
24,500
24,500
26,000
25,900
553,600
554,500
605,000
555,000
61,000
294,000
61,000
56,000
394,000
388,000
381,000
39,000
39,000
38,000
38,00039,00039,000381,000388,000394,00056,00061,000294,00061,000555,000605,000554,500553,60025,90026,00024,50024,50027,10029,00029,0000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
29,000
29,000
27,100
24,500
24,500
26,000
25,900
553,600
554,500
605,000
555,000
61,000
294,000
61,000
56,000
394,000
388,000
381,000
39,000
39,000
38,000
38,00039,00039,000381,000388,000394,00056,00061,000294,00061,000555,000605,000554,500553,60025,90026,00024,50024,50027,10029,00029,0000000000
       Accounts payable 
228,200
0
203,800
203,800
193,900
193,900
202,700
205,200
252,100
242,900
206,100
222,600
215,000
242,500
355,900
501,000
411,000
506,000
436,000
418,000
402,000
386,000
350,000
390,000
381,000
354,000
296,000
270,000
270,000296,000354,000381,000390,000350,000386,000402,000418,000436,000506,000411,000501,000355,900242,500215,000222,600206,100242,900252,100205,200202,700193,900193,900203,800203,8000228,200
       Other Current Liabilities 
383,200
0
184,500
428,800
171,500
364,500
1,042,700
368,900
362,900
381,400
363,700
455,400
410,300
485,700
810,500
872,200
904,000
805,000
706,000
746,000
844,000
896,000
869,000
924,000
816,000
891,000
574,000
409,000
409,000574,000891,000816,000924,000869,000896,000844,000746,000706,000805,000904,000872,200810,500485,700410,300455,400363,700381,400362,900368,9001,042,700364,500171,500428,800184,5000383,200
   > Long-term Liabilities 
0
0
0
516,900
0
432,400
2,829,000
2,788,500
2,843,000
2,813,900
2,594,500
2,620,400
2,358,200
2,388,700
7,021,600
7,140,500
6,947,000
6,863,000
7,521,000
7,302,000
7,332,000
7,123,000
6,590,000
6,500,000
6,711,000
7,092,000
6,945,000
6,898,000
6,898,0006,945,0007,092,0006,711,0006,500,0006,590,0007,123,0007,332,0007,302,0007,521,0006,863,0006,947,0007,140,5007,021,6002,388,7002,358,2002,620,4002,594,5002,813,9002,843,0002,788,5002,829,000432,4000516,900000
       Long term Debt Total 
0
0
0
0
0
0
0
2,443,300
2,436,600
2,382,000
2,335,600
2,330,500
2,035,600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000002,035,6002,330,5002,335,6002,382,0002,436,6002,443,3000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
168,400
175,700
96,400
106,600
150,300
208,900
312,900
322,100
247,000
237,000
220,000
261,000
242,000
242,000
225,000
229,000
245,000
411,000
432,000
411,000
411,000432,000411,000245,000229,000225,000242,000242,000261,000220,000237,000247,000322,100312,900208,900150,300106,60096,400175,700168,40000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
27,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000027,3000000000000000
> Total Stockholder Equity
7,027,900
7,027,900
7,790,800
7,790,800
7,780,300
7,586,600
5,137,100
5,197,500
5,196,200
5,265,500
5,487,700
5,546,900
6,661,500
6,651,900
8,344,200
8,475,900
8,007,000
7,980,000
7,682,000
7,538,000
7,612,000
7,140,000
6,745,000
7,289,000
7,480,000
7,420,000
6,134,000
6,223,000
6,223,0006,134,0007,420,0007,480,0007,289,0006,745,0007,140,0007,612,0007,538,0007,682,0007,980,0008,007,0008,475,9008,344,2006,651,9006,661,5005,546,9005,487,7005,265,5005,196,2005,197,5005,137,1007,586,6007,780,3007,790,8007,790,8007,027,9007,027,900
   Common Stock
7,474,300
0
8,047,400
8,036,900
7,947,500
7,947,500
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000007,947,5007,947,5008,036,9008,047,40007,474,300
   Retained Earnings Total Equity
0
0
0
0
0
0
0
16,400
0
0
93,800
84,300
33,800
-19,400
-154,400
-477,200
-538,000
-748,000
-852,000
-949,000
-901,000
-923,000
-972,000
-1,057,000
-954,000
-1,051,000
0
0
00-1,051,000-954,000-1,057,000-972,000-923,000-901,000-949,000-852,000-748,000-538,000-477,200-154,400-19,40033,80084,30093,8000016,4000000000
   Accumulated Other Comprehensive Income 
0
0
0
-256,600
0
-360,900
-210,300
-222,200
-250,400
-214,800
-252,500
-173,700
-242,600
-214,800
-121,800
303,000
-102,000
65,000
-146,000
-209,000
-186,000
-649,000
-1,007,000
-392,000
-310,000
-281,000
-482,000
-266,000
-266,000-482,000-281,000-310,000-392,000-1,007,000-649,000-186,000-209,000-146,00065,000-102,000303,000-121,800-214,800-242,600-173,700-252,500-214,800-250,400-222,200-210,300-360,9000-256,600000
   Capital Surplus 
0
0
0
0
0
0
5,347,400
5,403,300
5,398,700
5,396,500
5,646,400
5,636,300
6,870,300
6,886,100
8,620,400
8,650,100
8,647,000
8,663,000
8,680,000
8,696,000
8,699,000
8,712,000
8,724,000
8,738,000
8,744,000
8,752,000
0
0
008,752,0008,744,0008,738,0008,724,0008,712,0008,699,0008,696,0008,680,0008,663,0008,647,0008,650,1008,620,4006,886,1006,870,3005,636,3005,646,4005,396,5005,398,7005,403,3005,347,400000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
-456,900
0
-256,600
8,047,400
-360,900
7,947,500
5,347,400
5,403,300
5,398,700
5,396,500
5,646,400
5,636,300
6,870,300
6,886,100
8,620,400
8,650,100
8,647,000
8,663,000
8,680,000
8,696,000
8,699,000
8,712,000
8,724,000
8,738,000
8,744,000
8,752,000
8,763,000
8,777,000
8,777,0008,763,0008,752,0008,744,0008,738,0008,724,0008,712,0008,699,0008,696,0008,680,0008,663,0008,647,0008,650,1008,620,4006,886,1006,870,3005,636,3005,646,4005,396,5005,398,7005,403,3005,347,4007,947,500-360,9008,047,400-256,6000-456,900



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,417,000
Cost of Revenue-1,931,000
Gross Profit2,486,0002,486,000
 
Operating Income (+$)
Gross Profit2,486,000
Operating Expense-2,160,000
Operating Income326,000326,000
 
Operating Expense (+$)
Research Development327,000
Selling General Administrative1,295,000
Selling And Marketing Expenses0
Operating Expense2,160,0001,622,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-277,000
Other Finance Cost-5,000
Net Interest Income-272,000
 
Pretax Income (+$)
Operating Income326,000
Net Interest Income-272,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,195,0001,570,000
EBIT - interestExpense = -26,000
-1,195,000
-954,000
Interest Expense277,000
Earnings Before Interest and Taxes (EBIT)251,000-918,000
Earnings Before Interest and Taxes (EBITDA)945,000
 
After tax Income (+$)
Income Before Tax-1,195,000
Tax Provision--13,000
Net Income From Continuing Ops-1,144,000-1,182,000
Net Income-1,231,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,091,000
Total Other Income/Expenses Net-1,244,000272,000
 

Technical Analysis of Elanco
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Elanco. The general trend of Elanco is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Elanco's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Elanco Animal Health.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 13.91 < 14.35 < 14.45.

The bearish price targets are: 12.67 > 12.50 > 12.07.

Tweet this
Elanco Animal Health Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Elanco Animal Health. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Elanco Animal Health Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Elanco Animal Health. The current macd is -0.70012434.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Elanco price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Elanco. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Elanco price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Elanco Animal Health Daily Moving Average Convergence/Divergence (MACD) ChartElanco Animal Health Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Elanco Animal Health. The current adx is 36.94.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Elanco shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Elanco Animal Health Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Elanco Animal Health. The current sar is 12.69.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Elanco Animal Health Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Elanco Animal Health. The current rsi is 30.54. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Elanco Animal Health Daily Relative Strength Index (RSI) ChartElanco Animal Health Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Elanco Animal Health. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Elanco price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Elanco Animal Health Daily Stochastic Oscillator ChartElanco Animal Health Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Elanco Animal Health. The current cci is -81.02691595.

Elanco Animal Health Daily Commodity Channel Index (CCI) ChartElanco Animal Health Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Elanco Animal Health. The current cmo is -39.55487888.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Elanco Animal Health Daily Chande Momentum Oscillator (CMO) ChartElanco Animal Health Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Elanco Animal Health. The current willr is -79.19463087.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Elanco is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Elanco Animal Health Daily Williams %R ChartElanco Animal Health Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Elanco Animal Health.

Elanco Animal Health Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Elanco Animal Health. The current atr is 0.49386338.

Elanco Animal Health Daily Average True Range (ATR) ChartElanco Animal Health Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Elanco Animal Health. The current obv is -146,234,829.

Elanco Animal Health Daily On-Balance Volume (OBV) ChartElanco Animal Health Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Elanco Animal Health. The current mfi is 18.14.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Elanco Animal Health Daily Money Flow Index (MFI) ChartElanco Animal Health Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Elanco Animal Health.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Elanco Animal Health Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Elanco Animal Health based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.540
Ma 20Greater thanMa 5014.611
Ma 50Greater thanMa 10015.474
Ma 100Greater thanMa 20014.989
OpenGreater thanClose13.450
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Elanco with someone you think should read this too:
  • Are you bullish or bearish on Elanco? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Elanco? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Elanco Animal Health

I send you an email if I find something interesting about Elanco Animal Health.


Comments

How you think about this?

Leave a comment

Stay informed about Elanco Animal Health.

Receive notifications about Elanco Animal Health in your mailbox!